Exelixis reported $82.61M in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
Agios Pharmaceuticals AGIO:US USD -86647000 8.29M
Akebia Therapeutics AKBA:US USD -49080000 82.98M
Amgen AMGN:US USD 2.74B 562M
AstraZeneca AZN:LN USD 1.25B 706M
Bayer BAYN:GR EUR 1.2B 1.03B
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bluebird Bio BLUE:US USD -84781000 22.62M
Bristol Myers Squibb BMY:US USD 2.47B 117M
Cytokinetics CYTK:US USD -130687000 119.81M
Eisai 4523:JP JPY -2181000000 9.62B
Eli Lilly And LLY:US USD 1.68B 466.4M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
Exelixis EXEL:US USD 82.61M 1.09M
Genmab GEN:DC DKK 1.93B 684M
Glaxosmithkline GSK:US GBP 1.19B 110M
Immunogen IMGN:US USD -77429000 16.38M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
Macrogenics MGNX:US USD -24955000 16.85M
Merk MRK:US USD 3.99B 939M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Moderna Inc MRNA:US USD 1.17B 1.28B
Nektar Therapeutics NKTR:US USD -54301000 98.54M
Neurocrine Biosciences NBIX:US USD 87.8M 103.1M
Novartis NOVN:VX USD 2.17B 60M
Pfizer PFE:US USD 9.41B 2.69B
Puma Biotechnology PBYI:US USD 2.39M 9.61M
Seattle Genetics SGEN:US USD -192805000 59.69M
Takeda 4502:JP JPY 104.44B 46.08B
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
Xencor XNCR:US USD -38348000 10.35M
YTE INCY:US USD 138.38M 116.06M